Answers are grounded in this paper and cite their sources.
Prospective clinical study finds IV iron isomaltoside significantly improves hemoglobin in postpartum women, indicating an effective treatment option.
Introduction: Postpartum anemia, defined as hemoglobin levels below 10 g/dL, is a common and serious health concern in developing countries like India. It can impair maternal recovery, lactation, and overall well-being. Intravenous (IV) iron therapy is preferred over oral iron for its faster action and better efficacy in moderate to severe cases. Iron isomaltoside is a newer IV iron formulation that allows high-dose administration (up to 1000 mg) in a single sitting with minimal risk of hypersensitivity or free iron-related side effects. Materials & Methods :This is a Prospective and observational study. Clinical study of iv iron isomaltoside in the treatment of post partum anemia admitted in the department of OBG, BMCRC, BALLARI. Results: Among 69 women treated with IV iron isomaltoside, mean hemoglobin increased significantly from 8.1 ± 1.0 to 10.2 ± 1.2 g/dL, and serum ferritin from 18.5 ± 6.2 to 86.4 ± 15.3 ng/mL(p < 0.001 for both). Hemoglobin increased by >2 g/dLin 47.8% of patients, 1–2 g/dL in 39.1%, and <1 g/dLin 13%. Ferritin rose by >50 ng/mLin 59.4% of patients. Amoderate positive correlation was observed between hemoglobin and ferritin increases (r = 0.42, p < 0.001). Conclusion: Intravenous iron isomaltoside was effective in significantly improving hemoglobin and serum ferritin levels in women with postpartum anemia, with nearly half of the patients achieving a hemoglobin increase of more than 2 g/dLwithin two weeks.. These findings support the use of iron isomaltoside as a safe and efficient option for the rapid correction of postpartum anemia, particularly in resource-limited settings.
No takes yet. Share an insight, caveat, or question.
Mruthyunjaya et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: